Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Diabetes Care

Volumn 19, Issue 10, 1996, Pages 1045-1050

  Haffner, Steven M ^a,c   Klein, Barbara E K ^b   Moss, Scot E ^b   Klein, Ronald ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ESTRADIOL; ESTRONE; HEMOGLOBIN A1C; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY;

EID: 0004779165     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.10.1045     Document Type: Article

References (47)

1. Tikkanen MJ, Nikkila EA, Vantianen E: Natural estrogen as an effective treatment for type II hyperlipoproteinemia in postmenopausal women. Lancet 2:490-491, 1978
2. Wallentin L, Larsson-Cahn U: Metabolic and hormonal effects of post-menopausal women estrogen replacement treatment. II. Plasma lipids. Acta Endocrinol 86:597-607, 1977
3. Taggert H, Applebaum-Bowden D, Haffner S, Warnick R, Cheung M, Albers J, Chestnut C III, Hazzard WR: Reduction in high density lipoprotein by anabolic steroid (stanozolol) therapy for osteoporosis. Metabolism 31:1147-1152, 1982
4. Haffner S, Kushwaha R, Foster D, Hazzard W: Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 22:841-855, 1983
5. Beck P: Contraceptive steroids: modification of carbohydrate and lipid metabolism. Metabolism 22:841-855, 1973
6. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, Jacobs D, Frantz ID Jr: Lipoprotein-cholesterol distribution in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 61:302-315, 1980
7. Evans DJ, Hoffman RG, Kalkhoff RF, Kissebah AH: Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57:304-310, 1983
8. Haffner SM, Katz MS, Stern MP, Dunn JF: The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 37:683-688, 1988
9. Soler JT, Folsom AR, Kaye SA, Prineas RJ: Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin and estrone with lipids and lipoprotein in postmenopausal women. Atherosclerosis 79:21-27, 1989
10. Haffner SM, Dunn JF, Katz MS: Relationship of sex hormone binding globulin to lipid, lipoprotein, glucose and insulin concentrations in postmenopausal women. Metabolism 41:278-284, 1992
11. Semmens J, Rouse I, Beilin LJ, Masarei JR: Relationship of plasma HDL cholesterol to testosterone, estradiol and sex hormone binding globulin levels in men and women. Metabolism 32:428-432, 1983
12. Haffner SM, Katz MS, Stern MP, Dunn JF: The association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 9:136-143, 1989
13. Gorbach SL, Schaefer EJ, Woods M, Longcope C, Dwyer JT, Goldin BR, Morrill-LaBrode A, Dallal G: Plasma lipoprotein cholesterol and endogenous sex hormones in healthy young women. Metabolism 38:1077-1081, 1989
14. 4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 142:925-934, 1995
15. Barrett-Connor E: Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 117:807-811, 1992
16. Haffner SM, Valdez RA, Mykkänen L, Stern MP, Katz MS: Decreased testosterone and dehydroepiandrosterone sulfate are associated with increased insulin and glucose concentrations in non-diabetic men. Metobolism 43:599-603, 1994
17. Haffner SM, Mykkanen L, Valdez RA, Katz MS: Relationship of sex hormones to lipid and lipoproteins in non-diabetic men. J Clin Endocrinol Metab 77:1610-1615, 1993
18. Haffner SM, Karhapää P, Mykkänen L, Laakso M: Insulin resistance, body fat distribution and sex hormones in men. Diabetes 43:212-219, 1994
19. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: 16-year follow-up. Diabetes 23:111-115, 1974
20. Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors and 12-year mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
21. Moss SE, Klein R, Klein BEK: Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81:1158-1162, 1991
22. Andersson B, Mårin P, Lissner L, Vermeulen A, Bjömtorp P: Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411, 1994
23. Barrett-Connor E, Khow T, Yen SCC: Endogenous sex hormone levels in older men and women with diabetes mellitus. Am J Med 132:895-901, 1990
24. Cauley JA, Gutai JP, Kuller LH, Dai WL: Usefulness of sex steroid hormone levels in predicting coronary disease in men. Am J Cardiol 60:771-777, 1987
25. Barrett-Connor E, Khaw KT: Endogenous sex hormones and IHD in men. Circulation 78:539-545, 1988
26. Cauley JA, Gutai JP, Glynn NW, Paternostro-Boyles M, Cottington E, Kuller LH: Serum estrone concentrations and coronary artery disease in postmenopausal women. Arteriosder Thromb 14:14-18, 1994
27. Lapidus L, Lindstedt G, Lundberg P, Bengtsson C, Gredmark T: Concentrations of sex hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of IHD and overall mortality in postmenopausal women. Clin Chem 32:146-152, 1986
28. Hauner H, Bognar E, Blum A: Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 105:209-216, 1994
29. Hauner H, Stangl K, Burger K, Busch V, Bloomer H, Pfeifler EF: Sex hormone concentrations in men with angiographically assessed coronary artery disease - relationship to obesity and body fat distribution. Klin Wochenschr 69:664-668, 1991
30. Barrett-Connor E, Khaw KT, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality and IHD. N Engl J Med 315:1519-1524, 1986
31. Barrett-Connor E, Khaw KT: Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women (Letter). N Engl J Med 317:711, 1987
32. Nestler JE, Clore JN, Blackard WG: Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis? FASEB J 6:3073-3075, 1992
33. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
34. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
35. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Wisconsin Epidemiologic Study of Diabetic Retinopathy IX. Four year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107: 237-243, 1989
36. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Wisconsin Epidemiologic Study of Diabetic Retinopathy X. Four year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107:244-249, 1989
37. Moss SE, Klein R, Klein BE, Spennetta TL, Shrago ES: Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 41:645-649, 1988
38. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
39. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analyses of the insulin resistance syndrome (syndrome X). Diabetes 41:715-72, 1992
40. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease? (Review). Diabetologia 37:945-947, 1994
41. Wingard DL, Barrett-Connor EL, Ferrara A: Is insulin really a heart disease risk factor? (Review). Diabetes Care 18:1299-1304, 1995
42. Anderson DC: Sex hormone binding globulin. Clin Endocrinol 3:69-90, 1974
43. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L (for the MRFIT Research Group): Low levels of sex hormone binding globulin predict the development of non-insulin dependent diabetes mellitus in men. Am J Epidemiol 143:889-897, 1996
44. Nestler JE: Sex hormone binding globulin: a marker for hyperinsulinemia and/or insulin resistance (Editorial). J Clin Endocrinol Metab 76:273-274, 1993
45. DeFronzo RA: Lilly Lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
46. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO Jr, Pearson TA: Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 16:862-870, 1990
47. Orentriech N, Brind JL, Rizer RL, Vogelman JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555, 1984